{"id":635,"date":"2026-02-28T13:59:00","date_gmt":"2026-02-28T13:59:00","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/wearable-ecg-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T13:59:00","modified_gmt":"2026-02-28T13:59:00","slug":"wearable-ecg-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/wearable-ecg-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Wearable ECG: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Wearable ECG Introduction (What it is)<\/h2>\n\n\n\n<p>Wearable ECG is a device-based test that records the heart\u2019s electrical activity using sensors worn on the body.<br\/>\nIt belongs to the category of diagnostic monitoring tools, similar in purpose to standard electrocardiography (ECG).<br\/>\nIt is commonly encountered in cardiology when evaluating palpitations, suspected arrhythmias, or intermittent symptoms.<br\/>\nIt is also used in some settings for rhythm surveillance in people with known atrial fibrillation (AF).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Wearable ECG matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Arrhythmias can be intermittent, brief, and unpredictable. A standard 12-lead electrocardiogram (ECG) captures only a short time window, often when the patient is asymptomatic. Wearable ECG aims to extend rhythm observation into daily life, increasing the chance of capturing an abnormal rhythm at the moment symptoms occur or during routine activity.<\/p>\n\n\n\n<p>In clinical practice and education, Wearable ECG matters because it sits at the intersection of physiology (cardiac electrophysiology), diagnostic reasoning (matching symptoms to rhythm), and pragmatic care pathways (deciding who needs reassurance versus further testing). When an arrhythmia is documented, clinicians can more confidently connect a symptom (for example, \u201cskipped beats\u201d or \u201cracing heart\u201d) to a specific rhythm diagnosis (such as premature atrial contractions, supraventricular tachycardia, or atrial fibrillation). That diagnostic clarity can influence downstream decisions, including additional monitoring, medication choices, procedural referral, or anticoagulation discussions for AF when appropriate.<\/p>\n\n\n\n<p>Wearable ECG also has relevance for risk stratification in a broad sense. Some rhythm findings are benign in many contexts, while others may signal higher risk depending on underlying heart disease, symptom severity, and associated findings. Importantly, the value of Wearable ECG is not only in \u201cdetecting something,\u201d but in documenting rhythm in context\u2014timing, triggers, symptom correlation, and recurrence patterns\u2014while recognizing that interpretation and next steps vary by clinician and case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>Wearable ECG is best categorized by <strong>form factor<\/strong>, <strong>number of leads<\/strong>, and <strong>recording strategy<\/strong> rather than by \u201cstages.\u201d Common variants include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Single-lead, on-demand wearable ECG<\/strong><\/li>\n<li>Often integrated into a smartwatch or a small handheld sensor paired with a phone.<\/li>\n<li>Typically records a short strip when the user initiates a recording.<\/li>\n<li>\n<p>Useful for symptom-rhythm correlation when symptoms are frequent enough to capture.<\/p>\n<\/li>\n<li>\n<p><strong>Continuous patch monitors (wearable ECG patches)<\/strong><\/p>\n<\/li>\n<li>Adhesive patches worn on the chest for extended monitoring.<\/li>\n<li>Designed for near-continuous rhythm capture during routine activities.<\/li>\n<li>\n<p>Often used when symptoms are intermittent or when clinicians want broader rhythm surveillance.<\/p>\n<\/li>\n<li>\n<p><strong>Chest-strap or garment-based ECG<\/strong><\/p>\n<\/li>\n<li>Uses electrodes embedded in a strap or textile.<\/li>\n<li>Can be used in exercise contexts or longer-term monitoring depending on design.<\/li>\n<li>\n<p>Signal quality and comfort vary by device and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Event-triggered recorders (wearable event monitors)<\/strong><\/p>\n<\/li>\n<li>Records continuously but stores segments when triggered by the user or by an algorithm.<\/li>\n<li>\n<p>Often used for sporadic symptoms.<\/p>\n<\/li>\n<li>\n<p><strong>Multi-lead wearable systems (limited-lead or \u201cnear\u201d multi-lead)<\/strong><\/p>\n<\/li>\n<li>Some systems approximate additional leads through different contact positions.<\/li>\n<li>They may improve rhythm characterization in some cases but are not identical to a standard 12-lead ECG.<\/li>\n<\/ul>\n\n\n\n<p>These types differ in what they can reasonably detect, how much artifact they encounter, and how easily clinicians can interpret the results.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Wearable ECG is grounded in cardiac electrophysiology and the anatomy of the heart\u2019s conduction system. Key structures include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sinoatrial (SA) node<\/strong><\/li>\n<li>The usual pacemaker located in the right atrium.<\/li>\n<li>\n<p>Initiates impulses that spread through the atria, contributing to the <strong>P wave<\/strong> on ECG.<\/p>\n<\/li>\n<li>\n<p><strong>Atrioventricular (AV) node<\/strong><\/p>\n<\/li>\n<li>Receives atrial impulses and introduces a physiologic delay, supporting ventricular filling.<\/li>\n<li>\n<p>Conduction through the AV node influences the <strong>PR interval<\/strong> conceptually.<\/p>\n<\/li>\n<li>\n<p><strong>His\u2013Purkinje system<\/strong><\/p>\n<\/li>\n<li>The His bundle divides into bundle branches and Purkinje fibers, rapidly activating the ventricles.<\/li>\n<li>\n<p>Ventricular depolarization contributes to the <strong>QRS complex<\/strong>.<\/p>\n<\/li>\n<li>\n<p><strong>Atria and ventricles<\/strong><\/p>\n<\/li>\n<li>Atrial depolarization and ventricular depolarization\/repolarization create voltage changes that surface electrodes can detect.<\/li>\n<li>Structural or functional changes (for example, atrial enlargement or ventricular scar) can influence rhythm behavior and ECG patterns.<\/li>\n<\/ul>\n\n\n\n<p>ECG recordings reflect <strong>electrical potential differences<\/strong> detected by electrodes on the skin. Wearable ECG usually captures one or a few vectors of that electrical activity, which is sufficient for many rhythm questions (rate, regularity, presence of discernible P waves, and broad QRS morphology) but less comprehensive than a 12-lead ECG for spatial localization or ischemia evaluation.<\/p>\n\n\n\n<p>Physiology outside the heart also matters. Skin properties, sweat, motion, muscle activity, and electrode contact influence signal quality and artifact.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>Wearable ECG does not directly \u201ctreat\u201d disease; it measures electrical signals that arise from cardiac depolarization and repolarization. The mechanism can be understood in two layers:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\n<p><strong>Physiologic signal generation<\/strong>\n   &#8211; Ion channel activity across myocyte membranes generates action potentials.\n   &#8211; Coordinated conduction through atria, AV node, and ventricles produces organized wavefronts.\n   &#8211; Arrhythmias occur when impulse formation or conduction becomes abnormal (for example, re-entry circuits, ectopic foci, or conduction block).<\/p>\n<\/li>\n<li>\n<p><strong>Device signal acquisition and processing<\/strong>\n   &#8211; Electrodes detect voltage differences on the skin surface.\n   &#8211; The device amplifies and filters signals to create a readable tracing.\n   &#8211; Many systems apply algorithms to identify rhythm patterns (for example, irregularly irregular rhythm suggestive of AF).\n   &#8211; Signal quality depends on electrode contact, placement, motion, and noise filtering; these factors vary by device and patient factors.<\/p>\n<\/li>\n<\/ol>\n\n\n\n<p>Because wearable systems often use fewer leads than standard ECG, their \u201cview\u201d of the heart is narrower. This is usually adequate for rhythm detection but can limit detailed characterization (for example, localizing an accessory pathway or distinguishing some wide-complex tachycardias). Automated interpretations can be helpful but may be affected by artifact and atypical rhythms; clinician review is commonly important when results could change management.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Wearable ECG is most often used in scenarios where rhythm information is needed outside a clinic visit. Common indications include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Palpitations<\/strong><\/li>\n<li>\n<p>Sensation of fluttering, pounding, skipped beats, or rapid heartbeats.<\/p>\n<\/li>\n<li>\n<p><strong>Intermittent dizziness or near-syncope<\/strong><\/p>\n<\/li>\n<li>\n<p>Especially when episodes are brief and not captured on in-office testing.<\/p>\n<\/li>\n<li>\n<p><strong>Suspected paroxysmal atrial fibrillation (AF)<\/strong><\/p>\n<\/li>\n<li>\n<p>When symptoms are intermittent or when screening\/surveillance is being considered.<\/p>\n<\/li>\n<li>\n<p><strong>Post-treatment rhythm surveillance<\/strong><\/p>\n<\/li>\n<li>\n<p>After cardioversion, ablation procedures, or medication changes, depending on clinician goals.<\/p>\n<\/li>\n<li>\n<p><strong>Ectopy assessment<\/strong><\/p>\n<\/li>\n<li>\n<p>Characterizing premature atrial contractions (PACs) or premature ventricular contractions (PVCs) when symptom correlation is needed.<\/p>\n<\/li>\n<li>\n<p><strong>Exercise-related symptoms<\/strong><\/p>\n<\/li>\n<li>In selected contexts, to see whether symptoms during activity correlate with an arrhythmia (recognizing motion artifact limitations).<\/li>\n<\/ul>\n\n\n\n<p>Wearable ECG is generally not a stand-alone evaluation for chest pain, heart failure symptoms, or structural heart disease, although rhythm information may be part of broader assessment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Interpreting Wearable ECG involves combining the tracing with clinical context. In practice, evaluation often includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical history<\/strong><\/li>\n<li>Symptom description (onset, offset, triggers, duration).<\/li>\n<li>Associated features (syncope, chest discomfort, shortness of breath).<\/li>\n<li>\n<p>Past medical history, medications, stimulant use, sleep, and alcohol patterns.<\/p>\n<\/li>\n<li>\n<p><strong>Baseline testing as needed<\/strong><\/p>\n<\/li>\n<li>A standard 12-lead ECG is often used to assess baseline conduction, intervals, and evidence of prior infarction or hypertrophy.<\/li>\n<li>Additional tests (labs, echocardiography, stress testing) are considered based on presentation and clinician judgment.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">What clinicians look for on a wearable tracing<\/h3>\n\n\n\n<p>Because many Wearable ECG devices provide single-lead strips, interpretation emphasizes fundamentals:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Rate and regularity<\/strong><\/li>\n<li>Regular narrow-complex tachycardia patterns may suggest supraventricular tachycardia (SVT), while irregularly irregular rhythm raises suspicion for AF.<\/li>\n<li>\n<p>Sinus tachycardia is considered when P waves are present with a consistent relationship to QRS complexes.<\/p>\n<\/li>\n<li>\n<p><strong>P waves and atrial activity (when visible)<\/strong><\/p>\n<\/li>\n<li>Presence of organized P waves supports sinus rhythm or atrial tachycardia patterns.<\/li>\n<li>\n<p>Absence of consistent P waves with irregular rhythm can be consistent with AF, though artifact can mimic this.<\/p>\n<\/li>\n<li>\n<p><strong>QRS width and morphology (as best as a single lead allows)<\/strong><\/p>\n<\/li>\n<li>Wide-complex rhythms raise a differential that includes ventricular tachycardia, SVT with aberrancy, pacing, or pre-excitation patterns.<\/li>\n<li>\n<p>Single-lead data may be insufficient for definitive categorization in some cases.<\/p>\n<\/li>\n<li>\n<p><strong>Ectopy<\/strong><\/p>\n<\/li>\n<li>Premature beats may be captured and correlated with symptoms.<\/li>\n<li>The burden and patterning (isolated, bigeminy, couplets) may be suggested but can be difficult to quantify accurately without continuous monitoring.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Practical interpretation caveats<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Artifact recognition is central<\/strong><\/li>\n<li>Motion, muscle activity, loose contact, and electrical interference can create patterns that resemble arrhythmia.<\/li>\n<li>\n<p>A tracing\u2019s \u201cquality\u201d and the presence of a stable baseline influence interpretability.<\/p>\n<\/li>\n<li>\n<p><strong>Algorithm outputs are not identical to clinician interpretation<\/strong><\/p>\n<\/li>\n<li>Automated labels (for example, \u201cpossible AF\u201d) are screening signals, not definitive diagnoses by themselves.<\/li>\n<li>Final clinical interpretation often depends on review of the raw strip, symptom correlation, and other data.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Wearable ECG fits into management as a <strong>documentation tool<\/strong> rather than a treatment. Its main role is to inform clinical decisions by clarifying rhythm during symptoms or over time.<\/p>\n\n\n\n<p>General pathways in which wearable findings may influence care include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Reassurance and education<\/strong><\/li>\n<li>If recordings show normal sinus rhythm during symptoms, clinicians may broaden the differential (for example, anxiety, dehydration, thyroid disease, medication effects), depending on the situation.<\/li>\n<li>\n<p>If benign ectopy is documented and the clinical context is low risk, reassurance and trigger identification may be part of the plan (varies by clinician and case).<\/p>\n<\/li>\n<li>\n<p><strong>Escalation to formal rhythm monitoring<\/strong><\/p>\n<\/li>\n<li>If symptoms are infrequent or tracings are ambiguous, clinicians may use Holter monitoring, longer ambulatory ECG patches, or event monitors to improve diagnostic yield.<\/li>\n<li>\n<p>In higher-concern scenarios, more intensive monitoring strategies may be selected based on protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Arrhythmia-specific evaluation and treatment planning<\/strong><\/p>\n<\/li>\n<li>Documented AF can lead to clinician-led discussion about stroke risk assessment, rhythm versus rate control strategies, and whether additional evaluation for structural heart disease is appropriate.<\/li>\n<li>Documented SVT may prompt referral consideration for electrophysiology evaluation, medication options, or ablation discussion, depending on symptom burden and patient preference.<\/li>\n<li>\n<p>Wide-complex tachycardia concerns typically lead to more urgent, structured evaluation, but next steps vary by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Shared language between patient and clinician<\/strong><\/p>\n<\/li>\n<li>A time-stamped tracing can improve communication: what happened, when, and what the rhythm looked like.<\/li>\n<li>This can reduce uncertainty compared with symptom descriptions alone.<\/li>\n<\/ul>\n\n\n\n<p>Wearable ECG data are usually interpreted within a broader clinical picture rather than used in isolation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Wearable ECG is generally low risk, but it has important limitations and potential downsides:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>False positives and false negatives<\/strong><\/li>\n<li>Artifact can mimic AF or tachyarrhythmias.<\/li>\n<li>\n<p>Brief episodes may be missed, especially with on-demand recordings.<\/p>\n<\/li>\n<li>\n<p><strong>Limited lead perspective<\/strong><\/p>\n<\/li>\n<li>Single-lead recordings are often sufficient for rhythm screening but may be inadequate for complex rhythm discrimination or ischemia evaluation.<\/li>\n<li>\n<p>Wearable ECG is not a substitute for a diagnostic 12-lead ECG when a full electrical assessment is needed.<\/p>\n<\/li>\n<li>\n<p><strong>Signal artifact and user-dependent quality<\/strong><\/p>\n<\/li>\n<li>Motion, sweat, poor skin contact, and improper technique can degrade recordings.<\/li>\n<li>\n<p>Muscle tremor can resemble atrial activity or fibrillatory waves.<\/p>\n<\/li>\n<li>\n<p><strong>Skin irritation<\/strong><\/p>\n<\/li>\n<li>\n<p>Patch adhesives can cause irritation or allergic reactions in some users.<\/p>\n<\/li>\n<li>\n<p><strong>Data overload and anxiety<\/strong><\/p>\n<\/li>\n<li>\n<p>Frequent notifications or ambiguous results can increase worry and prompt unnecessary testing in some contexts.<\/p>\n<\/li>\n<li>\n<p><strong>Privacy and data governance considerations<\/strong><\/p>\n<\/li>\n<li>\n<p>Device ecosystems may store health data; how data are used and shared depends on device settings, platforms, and policies.<\/p>\n<\/li>\n<li>\n<p><strong>Equity and access<\/strong><\/p>\n<\/li>\n<li>Costs, smartphone requirements, and digital literacy can influence who benefits from these technologies.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Wearable ECG does not determine prognosis by itself; prognosis depends on the <strong>underlying rhythm diagnosis<\/strong>, associated symptoms (such as syncope), comorbidities (for example, structural heart disease), and how promptly clinically meaningful arrhythmias are identified and managed.<\/p>\n\n\n\n<p>Follow-up considerations often include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptom\u2013rhythm correlation over time<\/strong><\/li>\n<li>\n<p>Clinicians may ask whether symptoms persist despite normal tracings, whether episodes cluster with triggers, and whether the rhythm pattern evolves.<\/p>\n<\/li>\n<li>\n<p><strong>Confirmation and characterization<\/strong><\/p>\n<\/li>\n<li>\n<p>A wearable tracing suggestive of AF or another arrhythmia may prompt confirmation with medical-grade ECG assessment, depending on clinical context and protocol.<\/p>\n<\/li>\n<li>\n<p><strong>Monitoring strategy adjustments<\/strong><\/p>\n<\/li>\n<li>If episodes are rare, longer continuous monitoring may be considered.<\/li>\n<li>\n<p>If episodes are frequent but unclear due to artifact, technique or device type may be reconsidered.<\/p>\n<\/li>\n<li>\n<p><strong>Underlying disease assessment<\/strong><\/p>\n<\/li>\n<li>\n<p>Discovery of a clinically significant arrhythmia often triggers evaluation for contributing factors (structural heart disease, ischemia, thyroid disease, sleep apnea), varying by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Device performance over time<\/strong><\/p>\n<\/li>\n<li>Adherence (wear time), skin tolerance, and recording quality influence the usefulness of wearable monitoring.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Wearable ECG Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does Wearable ECG actually measure?<\/strong><br\/>\nIt measures voltage changes on the skin produced by the heart\u2019s electrical depolarization and repolarization. Most wearables record one electrical \u201cview\u201d (one lead) or a limited set of views. The output is an ECG strip that can be reviewed for rhythm and basic conduction features.<\/p>\n\n\n\n<p><strong>Q: How is Wearable ECG different from a 12-lead ECG in clinic?<\/strong><br\/>\nA 12-lead ECG provides multiple electrical perspectives, which helps with localization (for example, infarct patterns, axis, conduction blocks) and more detailed interpretation. Wearable ECG usually provides fewer leads but can capture rhythms during real-world activities and intermittent symptoms. They are complementary tools rather than interchangeable in many scenarios.<\/p>\n\n\n\n<p><strong>Q: Can Wearable ECG detect atrial fibrillation (AF)?<\/strong><br\/>\nWearable ECG can sometimes capture patterns consistent with AF, especially if the episode occurs during recording or during continuous patch wear. Many devices also provide algorithm-based AF notifications, which may help prompt clinical review. Whether an AF label is considered confirmed depends on clinician assessment and local protocol.<\/p>\n\n\n\n<p><strong>Q: Can Wearable ECG detect a heart attack?<\/strong><br\/>\nWearable ECG is primarily designed for rhythm monitoring, not comprehensive ischemia evaluation. Because many devices use single-lead recordings, they may not reliably detect ST-segment changes in a way that replaces a clinical 12-lead ECG. Clinicians typically rely on symptoms, 12-lead ECGs, and biomarkers for heart attack evaluation.<\/p>\n\n\n\n<p><strong>Q: If a wearable shows an \u201cabnormal rhythm,\u201d what typically happens next?<\/strong><br\/>\nCommon next steps include clinician review of the actual tracing, correlation with symptoms, and deciding whether confirmation with medical-grade ECG monitoring is needed. Additional testing depends on the rhythm suspected, symptom severity, and the patient\u2019s overall risk profile. Management decisions vary by clinician and case.<\/p>\n\n\n\n<p><strong>Q: Does Wearable ECG replace a Holter monitor or event monitor?<\/strong><br\/>\nSometimes it can reduce the need for other monitoring when it captures a clear, clinically meaningful rhythm during symptoms. In other cases, formal ambulatory monitors are preferred because they provide continuous, standardized recordings and quantification. The choice depends on symptom frequency, diagnostic question, and local workflow.<\/p>\n\n\n\n<p><strong>Q: How accurate are Wearable ECG devices?<\/strong><br\/>\nAccuracy varies by device design, lead configuration, recording conditions, and the rhythm in question. Motion artifact and poor contact can reduce reliability, while high-quality recordings can be quite interpretable for basic rhythm questions. Clinician verification is often important when results may change clinical decisions.<\/p>\n\n\n\n<p><strong>Q: Is Wearable ECG safe to use?<\/strong><br\/>\nAs a recording tool, wearable ECG is generally low risk. Potential issues include skin irritation from adhesives and the indirect harms of misinterpretation or anxiety from notifications. Safety considerations also include data privacy and how results are communicated and acted upon.<\/p>\n\n\n\n<p><strong>Q: Can I use Wearable ECG during exercise?<\/strong><br\/>\nSome systems can record during activity, but movement and sweat can increase artifact. In practice, exercise recordings may be helpful for certain symptom-triggered episodes, but interpretability varies. Clinicians often consider exercise context alongside other testing when exertional symptoms are reported.<\/p>\n\n\n\n<p><strong>Q: What rhythms are hardest to interpret with Wearable ECG?<\/strong><br\/>\nShort, irregular episodes with heavy artifact can be challenging. Distinguishing certain supraventricular tachycardias, atrial flutter with variable conduction, or wide-complex tachycardias may require more leads or more controlled recordings. When the diagnostic stakes are high, clinicians may prefer medical-grade multi-lead monitoring.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wearable ECG is a device-based test that records the heart\u2019s electrical activity using sensors worn on the body. It belongs to the category of diagnostic monitoring tools, similar in purpose to standard electrocardiography (ECG). It is commonly encountered in cardiology when evaluating palpitations, suspected arrhythmias, or intermittent symptoms. It is also used in some settings for rhythm surveillance in people with known atrial fibrillation (AF).<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-635","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=635"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/635\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}